Back

Antithrombotic strategy for patients with anticoagulation indication undergoing percutaneous coronary intervention: meta-analysis of randomised controlled trials

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Percutaneous coronary syndrome: pharma and devices Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Tom Kai Ming Wang

Auckland City Hospital, Auckland (New Zealand)

26 More presentations in this session

Presentation thumbnail
Doctor G. Gallone (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor S. Dani (Ahmedabad, IN)
Presentation thumbnail
Doctor H. Matsuda (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Doctor I. Menown (Craigavon, GB)
Abstract
Presentation thumbnail
Miss L. Kerkmeijer (Zwolle, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Oral anticoagulation monotherapy versus combination antithrombotic therapy in patients with AF and PCI with a drug-eluting stent implantation: a systematic review and meta-analysis
23 April 2026
thumbnail
Webinar
Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series
28 November 2023
thumbnail
Congress Presentation
Perioperative management of antithrombotic therapy.
29 August 2022
thumbnail
Congress Presentation
The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources